Device
FitBit Flex
FitBit Flex is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
withdrawn125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Incentivizing Lifestyle Modification to Reduce Disease Burden
NCT02945332
completednot_applicable
Long-Term Effects of Torso-Weighting
NCT02743312
withdrawnnot_applicable
Exercise, Activity and Smoking in Young Adults
NCT02527876
completed
A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients
NCT02320513
Clinical Trials (4)
Showing 4 of 4 trials
NCT02945332Not Applicable
Incentivizing Lifestyle Modification to Reduce Disease Burden
NCT02743312Not Applicable
Long-Term Effects of Torso-Weighting
NCT02527876Not Applicable
Exercise, Activity and Smoking in Young Adults
NCT02320513
A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4